The Medical Testing, Analyzing, and Diagnostic Equipment industry on FinBizNet covers 7 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 7 |
|---|---|
| Combined market cap | ₹17,028 Cr |
| Median P/E (profitable companies) | 32.1 |
| Median return on equity | 12.3% |
| Companies with latest quarterly results | 4 of 7 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Molbio Diagnostics Limited | ₹14,676 Cr | 86.2 | — | ₹408 Cr | ₹53 Cr | Q1 FY27 |
| Hemant Surgical Industries Lim | ₹825 Cr | 38.0 | — | — | — | — |
| Credent Connect N Care | ₹595 Cr | 23.4 | — | — | — | — |
| QMS Medical Allied Services Limited | ₹334 Cr | 32.1 | 12.3% | ₹57 Cr | ₹4 Cr | Q1 FY27 |
| Nureca Ltd | ₹296 Cr | 147.1 | 1.1% | ₹59 Cr | ₹4 Cr | Q2 FY27 |
| Earkart Limited | ₹164 Cr | 29.9 | — | ₹0 Cr | ₹0 Cr | Q2 FY26 |
| Avience Biomedicals Limited | ₹138 Cr | 11.6 | 27.9% | — | — | — |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 7 listed companies in the Medical Testing, Analyzing, and Diagnostic Equipment industry: Molbio Diagnostics Limited, Hemant Surgical Industries Lim, Credent Connect N Care, QMS Medical Allied Services Limited, Nureca Ltd, Earkart Limited, Avience Biomedicals Limited.
By market capitalisation, the largest Medical Testing, Analyzing, and Diagnostic Equipment companies are Molbio Diagnostics Limited (₹14,676 Cr), Hemant Surgical Industries Lim (₹825 Cr), Credent Connect N Care (₹595 Cr), QMS Medical Allied Services Limited (₹334 Cr), Nureca Ltd (₹296 Cr).
The 7 Medical Testing, Analyzing, and Diagnostic Equipment companies tracked on FinBizNet have a combined market capitalisation of about ₹17,028 Cr.
The median price-to-earnings ratio across 7 profitable Medical Testing, Analyzing, and Diagnostic Equipment companies is 32.1, and the median return on equity across the industry is 12.3%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Medical Testing, Analyzing, and Diagnostic Equipment industry.